ArticleNature communications2026
C2orf74 orchestrates germ-Leydig crosstalk to inhibit white adipose tissue browning in male mice.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Sex differences in obesity are well recognized; however, the identification of sex-specific obesity genes and the mechanisms through which they affect obesity development remain elusive. Here, we identify a germ-cell-specific gene C2orf74, whose expression is responsive to high-fat diet (HFD) and promotes HFD-induced obesity in male mice by restraining lipolysis and limiting the browning of white adipocytes through suppression of androgen receptor signaling, but not in females. Additionally, C2orf74's expression increases with aging, contributing to aging-related obesity and metabolic comorbidities in chow-fed male mice. We demonstrate that C2orf74 is an ER-residing transmembrane protein that anchors and stabilizes dolichol phosphate mannose synthase 1 (Dpm1) on the ER membrane, facilitating Dpm1-mediated glycosylation and secretion of Bpifa3 from germ cells. As a paracrine regulator, Bpifa3 transcriptionally suppresses the expression of testosterone biosynthesis enzymes in Leydig cells. Therapeutically, we demonstrate that antisense oligonucleotide (ASO) targeting C2orf74 protects male mice from HFD-induced obesity. Thus, our study defines a role for germ-Leydig cell crosstalk, mediated by C2orf74, in the white adipocytes browning in both age-associated and diet-induced obesity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.